Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Andrew Witty
Biotech
WHO tasks ex-GSK CEO Witty with hastening COVID-19 vaccine R&D
Witty is taking a leave of absence from his job at UnitedHealth Group until around the end of the year to co-lead the WHO initiative.
Nick Paul Taylor
Apr 15, 2020 8:00am
Chutes & Ladders—Andrew Witty shifts to PBM as Optum's CEO
Mar 16, 2018 4:02am
Witty to head up new U.K. speedy drug/device review system
Nov 3, 2017 4:27am
Chutes & Ladders—Ex-GSK CEO Witty joins venture capital
Sep 22, 2017 7:00am
Ex-GlaxoSmithKline CEO Witty joins Hatteras as venture partner
Sep 19, 2017 7:31am
GSK to shutter central neuroscience R&D hub in China
Aug 3, 2017 10:46am
